RYAN PYLES: Open Payments
NPI 1003371410 · RAPHINE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,248 in 67 payments from 14 companies in 2025. Trend: 2023 $1,942 · 2024 $1,379 · 2025 $1,248
Food & beverage: $1,248
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $351 |
| Novo Nordisk Inc | 10 | $273 |
| AstraZeneca Pharmaceuticals LP | 5 | $119 |
| Lilly USA, LLC | 5 | $102 |
| PFIZER INC. | 4 | $90 |
| Amgen Inc. | 3 | $64 |
| IBSA Pharma Inc. | 2 | $46 |
| Exact Sciences Corporation | 2 | $37 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Dexcom, Inc. | 1 | $33 |
Products named: QULIPTA, MOUNJARO, UBRELVY, Ozempic, VRAYLAR, Wegovy, NURTEC ODT, BREZTRI.
Industry payments across VA — which companies pay providers there.
